Quality: A Commitment to Patient Care
Indian medicines now reach nearly every country in the world, with pharmaceutical exports surpassing $30 billion in 2024. At the core of this global footprint lies an unwavering commitment: Quality.
In 2015, Indian pharmaceutical companies set aside competitive boundaries to collaborate under a shared vision — to make India a global benchmark for pharmaceutical quality and excellence. This led to the creation of the IPA Quality Forum, a first-of-its-kind industry platform established under the leadership of IPA.
Over the past decade, the IPA Quality Forum has fostered peer-to-peer learning among leading companies, built strong bridges with global regulatory agencies, developed best practice guidelines on key quality priorities, spearheaded quality culture and capability building initiatives, piloted metrics for performance benchmarking, created a dynamic knowledge-sharing platform uniting stakeholders across pharma and healthcare.
Today, the IPA Quality Forum continues to drive India’s quality evolution — not just in compliance, but in culture, leadership, and global trust.
Leading Conversations on Pharma Quality
IPA has hosted 25+ industry-shaping events, including its flagship Global Pharmaceutical Quality Summit (GPQS) and Advanced GMP (AGMP) Workshops, delivering over 180 technical sessions. These platforms are central to the IPA Quality Forum’s mission to embed quality excellence across the pharma value chain.
Global Pharmaceutical Quality Summit (GPQS)
Since 2016, GPQS has become a globally respected forum for advancing pharmaceutical quality — bringing together regulators, industry leaders, and technical experts to tackle challenges and shape the future of compliance and innovation.
In February 2025, IPA celebrated the 10th edition of the Summit with the theme “Navigating the Next Decade for Global Excellence.” The event featured 50+ expert speakers across 11 sessions, spotlighting global trends in digital transformation, supply chain resilience, AI in manufacturing, and sustainability.
Learn more →Advanced GMP Workshop (AGMP)
The Advanced GMP Workshop focuses on training and regulatory preparedness — equipping quality professionals and regulators with tools for implementing cGMP, data integrity, risk-based audits, and harmonization with WHO-GMP and ICH guidelines. Led by senior officials from CDSCO, DCGI, and global agencies, the workshop reinforces India’s commitment to compliance culture and patient-centric quality systems.
Championing Best Practices in Pharma
Over the past decade, IPA has developed 20+ technical guidance documents covering the entire pharmaceutical quality lifecycle — with contributions from 100+ industry experts and dissemination to over 25,000 professionals.
These documents reflect best practices from across the industry and are vetted by regulatory stakeholders to ensure alignment with evolving compliance standards. Key topics include traceability, impurity control, PAT, technology transfer, cleaning and sterilization, data integrity, human error reduction, and regulatory best practices.
By fostering collaboration over competition, IPA continues to strengthen India's reputation for quality on the global stage.
Explore Best Practices →Global Pharmaceutical Quality Summit (GPQS)
The Global Pharmaceutical Quality Summit, hosted annually by IPA, is India’s premier platform dedicated to elevating quality across the pharmaceutical value chain. In its 10th edition in 2025, the Summit brought together over 200 global experts and regulators — including the US FDA, MHRA, EDQM, and WHO — to explore the future of quality through themes like digital transformation, resilient supply chains, AI-enabled manufacturing, and sustainability. With keynote addresses from IPA leadership, NITI Aayog, and the DCGI, and the release of landmark reports on operational excellence and risk mitigation, the Summit reaffirmed India’s ambition to set global benchmarks in pharmaceutical quality — not just in compliance, but in culture, innovation, and trust.
Advanced GMP Workshop (AGMP)
The Advanced GMP Workshop focuses on training and regulatory preparedness — equipping quality professionals and regulators with tools for implementing cGMP, data integrity, risk-based audits, and harmonization with WHO-GMP and ICH guidelines. Led by senior officials from CDSCO, DCGI, and global agencies, the workshop reinforces India’s commitment to compliance culture and patient-centric quality systems.
Building Global Trust
India’s quality advantage is not just certified — it’s globally proven. Across every continent, Indian pharmaceutical companies meet the most demanding international standards — delivering safe, effective, and trusted medicines at scale.
750+
USFDA-approved sites
Highest outside the United States
2,050
WHO-GMP-certified facilities
Global benchmark for pharma quality
286
EDQM-compliant plants
Meeting strict European quality standards
−50%
Drop in FDA inspection issues
From 23% (2014) to 11% (2024)
750+
FDA registered generic manufacturing sites
Highest globally
2,050
WHO-GMP-certified facilities
Global benchmark for pharma quality
286
EDQM-compliant plants
Meeting strict European quality standards
−50%
Drop in FDA inspection issues
From 23% (2014) to 11% (2024)
Certifications That Build Global Trust
India’s quality advantage is not just certified — it’s globally proven. Across every continent, Indian pharmaceutical companies meet the most demanding international standards — delivering safe, effective, and trusted medicines at scale.
750+
USFDA-approved sites
Highest outside the United States
2,050
WHO-GMP-certified facilities
Global benchmark for pharma quality
286
EDQM-compliant plants
Meeting strict European quality standards
−50%
Drop in FDA inspection issues
From 23% (2014) to 11% (2024)